Eisai
4523.T
#2624
Rank
C$9.66 B
Marketcap
C$34.24
Share price
-1.69%
Change (1 day)
-7.59%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.23. an increase over its 2024 EPS that were of C$1.38.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025C$1.5511.85%
2024C$1.38-32.63%
2023C$2.055.52%
2022C$1.94-74.01%
2021C$7.48-66.58%
2020C$22.3898.24%
2019C$11.2917.01%
2018C$9.6537.78%
2017C$7.00-27.62%
2016C$9.6735.33%
2015C$7.15-2.82%
2014C$7.36-27.66%
2013C$10.17-27.49%
2012C$14.03-12.67%
2011C$16.0688.08%
2010C$8.54-11.06%
2009C$9.60-390.15%
2008C-$3.31-127.78%
2007C$11.9111.78%
2006C$10.664.38%
2005C$10.217.4%
2004C$9.5143.03%
2003C$6.6525.09%
2002C$5.3152.67%
2001C$3.4869.76%
2000C$2.05